Is Potassium Good for Diabetics? Benefits and Risks

Potassium plays a genuinely important role in blood sugar regulation, and research consistently links higher potassium levels with a lower risk of developing type 2 diabetes. But the relationship is not straightforward for people who already have diabetes, because the very complications and medications that come with the disease can make potassium dangerously difficult for the body to manage. Whether potassium is “good” for you as a diabetic depends largely on how well your kidneys work and what medications you take.

Lower Potassium Levels Are Tied to Higher Diabetes Risk

One of the more consistent findings in the research is that people with lower blood potassium levels face a greater chance of developing type 2 diabetes. A large Japanese cohort study found that people in the lowest third of serum potassium had roughly 57% higher risk of developing diabetes compared to those in the highest third, even after accounting for other known risk factors. Each half-point drop in potassium (measured in mmol/L) was linked to a 45% jump in diabetes risk.¹ A dose-response meta-analysis pooling data from multiple prospective studies confirmed the pattern: for every 1 mmol/L increase in serum potassium, the risk of type 2 diabetes dropped by about 17%.²

These are observational findings, so they do not prove that raising your potassium intake will prevent diabetes. People who eat more potassium-rich foods also tend to eat more fruits, vegetables, and whole grains, all of which have their own protective effects. Researchers have called for randomized clinical trials to determine whether potassium supplementation itself could reduce diabetes risk, particularly in higher-risk groups, but those trials have not yet been completed.³ Still, the association is strong enough and consistent enough across studies that it merits attention.⁴

How Potassium Helps Regulate Insulin

The connection between potassium and blood sugar is not just statistical. Potassium is directly involved in the process by which your pancreas releases insulin. Beta cells in the pancreas contain potassium-sensitive channels that respond to changes in blood sugar. When glucose enters a beta cell and gets metabolized, the resulting energy shifts close these potassium channels, which changes the electrical charge across the cell membrane. That change in charge opens calcium channels, and the influx of calcium triggers the cell to release insulin.⁵

When blood potassium runs low, this chain of events can falter. The beta cells do not depolarize as effectively, and insulin release can be blunted. For someone already dealing with insulin resistance, even a modest reduction in the body’s ability to secrete insulin can tip the balance toward poorly controlled blood sugar. This is one reason why medications that drain potassium from the body, like certain diuretics, have long been flagged as a concern for people at risk of diabetes.

Blood Pressure and Cardiovascular Benefits

Heart disease is the leading cause of death among people with diabetes, and high blood pressure is one of the biggest risk factors driving that. Potassium has a well-documented ability to lower blood pressure, working partly by encouraging the kidneys to excrete sodium and partly by relaxing blood vessel walls. Multiple intervention trials and meta-analyses have confirmed these effects, leading researchers to suggest that increasing dietary potassium may benefit blood pressure and possibly glucose metabolism in many populations.⁶

For diabetics with healthy kidneys, eating a potassium-rich diet offers a two-for-one advantage: better blood pressure control and potentially improved insulin sensitivity. Potassium-enriched salt substitutes, which replace some sodium chloride with potassium chloride, have been studied as a practical way to achieve this. They can meaningfully lower blood pressure, but they come with a warning for people whose kidneys cannot efficiently clear extra potassium.⁷ For those individuals, the risk of dangerously high potassium levels may outweigh the blood pressure benefits.

When Kidney Disease Changes the Equation

Here is where the story turns. Diabetes is the most common cause of chronic kidney disease (CKD), and as kidney function declines, the body loses its primary mechanism for getting rid of excess potassium. Diabetic patients with CKD are substantially more prone to hyperkalemia, meaning potassium levels climb above the safe range.⁸ A large Danish population study found that diabetes was a significant independent risk factor for elevated potassium levels in CKD patients.⁹

The severity of kidney impairment matters. In one study comparing diabetic and non-diabetic CKD patients, the difference in hyperkalemia rates was most pronounced at moderate kidney impairment (stage 3 CKD), where diabetics had significantly higher rates. At more advanced kidney disease (stage 4), both groups had equally high rates of hyperkalemia, suggesting that severe kidney damage overwhelms other factors.¹⁰

Interestingly, hyperkalemia can show up in diabetic patients even before their kidney function has measurably declined. A condition called type IV renal tubular acidosis, which is relatively common in diabetes, impairs the kidney’s ability to excrete potassium even when overall filtration is still adequate. It tends to cause mild hyperkalemia and is treatable once identified, but it often goes unrecognized.¹¹

Medications That Raise Potassium Risk

Many diabetics take blood pressure medications that belong to a class known as RAAS inhibitors. These include ACE inhibitors and angiotensin receptor blockers (ARBs), which are frequently prescribed because they protect the kidneys and heart. The trade-off is that these drugs reduce the body’s ability to excrete potassium. Among diabetic patients in one study, about a quarter of those on ACE inhibitors and over a third of those on ARBs had elevated potassium levels.¹²

The risk climbs steeply when these drugs are combined. A systematic review and meta-analysis of patients with diabetic kidney disease found that dual RAAS blockade (using both an ACE inhibitor and an ARB together) roughly doubled the risk of hyperkalemia compared to using just one. Adding a steroidal mineralocorticoid receptor antagonist like spironolactone on top of an ACE inhibitor or ARB increased hyperkalemia risk more than fivefold.¹³ Researchers have developed scoring tools that incorporate kidney function, baseline potassium, diabetes status, heart failure, and medication use to predict who is most likely to develop hyperkalemia after starting these drugs.¹⁴

Diuretics add another layer of complexity. Thiazide-type diuretics, commonly prescribed for blood pressure, tend to push potassium levels down. That potassium loss can worsen blood sugar control. Non-potassium-sparing diuretics cause dose-dependent potassium depletion, and they also increase glucose and insulin resistance, which is why prescribing guidelines have long urged caution with diuretics in diabetics.¹⁵ The situation creates a balancing act: one set of medications pushes potassium dangerously high, while another pushes it dangerously low, and the patient needs both for different reasons.

Newer Diabetes Drugs May Help With Potassium Balance

A more encouraging development involves SGLT2 inhibitors, a class of diabetes drugs that includes empagliflozin, dapagliflozin, and canagliflozin. These medications, originally designed to lower blood sugar by making the kidneys excrete glucose in urine, appear to also reduce the risk of hyperkalemia. A large population-based study found that people taking SGLT2 inhibitors alongside RAAS inhibitors had lower rates of hyperkalemia than those on RAAS inhibitors alone, with roughly 11% fewer hyperkalemia events overall and 39% fewer hospital encounters related to high potassium.¹⁶

A separate study comparing different diabetes drug classes found that SGLT2 inhibitors were associated with a 25% lower rate of hyperkalemia than DPP-4 inhibitors, with about seven fewer hyperkalemia events per thousand person-years.¹⁷ The mechanism likely involves their mild diuretic effect, which increases potassium excretion through the kidneys. For diabetics who need to stay on heart- and kidney-protective RAAS inhibitors but keep running into potassium problems, SGLT2 inhibitors represent a genuinely useful addition to the regimen.

Potassium Binders as a Safety Net

Sometimes the best approach is not to restrict potassium or stop protective medications but to use drugs that remove excess potassium from the body. Newer potassium binders, such as patiromer and sodium zirconium cyclosilicate, work in the gut by trapping potassium before it can be absorbed, and they have reshaped how doctors manage hyperkalemia in patients with diabetes, CKD, and heart failure.

A systematic review and meta-analysis found that these newer potassium binders reduced hyperkalemia events by about 28% and lowered serum potassium by roughly 0.7 mEq/L. They also improved the ability of patients to maintain or escalate their RAAS inhibitor doses by 38%, which matters because stopping those medications worsens long-term kidney and heart outcomes.¹⁸ The National Kidney Foundation has endorsed these agents as tools that help patients stay on essential blood pressure medications rather than having to discontinue them due to potassium concerns.¹⁹

Potassium Swings During Diabetic Emergencies

Diabetic ketoacidosis (DKA) throws potassium levels into chaos. Although total body potassium is usually depleted during DKA because of fluid loss and acidosis-driven shifts, the initial blood potassium reading can look normal or even high. That is because acidosis pushes potassium out of cells and into the bloodstream, masking the underlying deficit. Once insulin treatment begins and fluid resuscitation corrects the acidosis, potassium rushes back into cells and blood levels can plummet. Low potassium during DKA treatment is common and can be dangerous, causing heart rhythm disturbances and muscle weakness.²⁰

This is why potassium replacement is a standard part of DKA treatment protocols. In rare cases, patients present with severe low potassium before insulin is even given, which requires aggressive potassium replacement before insulin therapy can safely begin. The key takeaway for patients is that DKA is a medical emergency where potassium monitoring happens hour by hour, and it illustrates how dramatically the mineral can swing in uncontrolled diabetes.

The Magnesium Connection

Low magnesium is common in diabetes and has a subtle but clinically important relationship with potassium. When magnesium is depleted, the kidneys waste potassium more readily, and potassium levels become difficult to correct even with direct supplementation. This phenomenon, called refractory potassium repletion, has been documented in clinical settings for decades. Replacing magnesium alongside potassium in uncontrolled diabetes has been associated with improved outcomes.²¹ If your doctor finds that your potassium stays stubbornly low despite supplementation, checking magnesium levels is a reasonable next step.

Practical Guidance on Potassium-Rich Foods

For diabetics with normal kidney function and no medications that raise potassium, eating potassium-rich foods is generally beneficial. Good sources include leafy greens, beans, bananas, potatoes, avocados, tomatoes, oranges, and fish. These foods come packaged with fiber, vitamins, and other compounds that support blood sugar control, so the potassium is rarely arriving in isolation. A dietary pattern rich in these foods has been associated with lower diabetes risk in observational studies, though separating the effect of potassium specifically from the overall diet quality remains difficult.³

For diabetics with CKD (even mild or moderate), the situation requires more care. Dietitians working with kidney patients often provide specific guidance on limiting high-potassium foods, and blood potassium levels need to be monitored regularly. Potassium supplements or salt substitutes should not be started without medical supervision in this group, given the documented risks of hyperkalemia and its potential consequences, including dangerous heart rhythm disturbances.⁷

A practical rule of thumb: if you have diabetes but your kidney function tests are normal and you are not on ACE inhibitors, ARBs, or potassium-sparing diuretics, eating potassium-rich whole foods is almost certainly fine and likely helpful. If any of those conditions apply, your potassium intake deserves a conversation with your doctor, ideally guided by actual blood work rather than guesswork.

Potassium and Gestational Diabetes

The relationship between potassium and diabetes risk may extend to pregnancy. A case-control study in Chinese women examined dietary patterns and gestational diabetes risk. A “vitamin pattern” diet rich in several nutrients, including potassium, calcium, folate, fiber, and various vitamins, was associated with about a 9-10% decrease in gestational diabetes risk for each quartile increase in the pattern score across preconception and early pregnancy.²² Because this was a dietary pattern study rather than an isolated nutrient trial, the benefit cannot be attributed to potassium alone. But it reinforces the broader theme: diets naturally rich in potassium tend to be diets that protect metabolic health, whether or not potassium itself is the active ingredient.

Why “Good or Bad” Is the Wrong Question

The frustrating reality is that potassium sits at the center of competing risks for many diabetics. Too little impairs insulin secretion, worsens blood pressure, and may accelerate the progression toward diabetes or make existing diabetes harder to control. Too much threatens the heart, especially when the kidneys cannot keep pace. The same person might swing between these two extremes depending on their hydration, medications, a change in kidney function, or an acute illness like DKA. This is why endocrinologists and nephrologists tend to monitor potassium levels routinely in diabetic patients and adjust dietary advice and medications based on actual numbers rather than blanket recommendations. A serum potassium value of 4.0 mmol/L in a diabetic with healthy kidneys means something very different from the same reading in a diabetic on dual RAAS blockade with stage 3 CKD, because the latter patient’s margin for error is much thinner.

Blood work matters more than generalized dietary advice here. If you have diabetes and have not had your potassium checked recently, asking about it at your next visit is a small step that can shape some surprisingly important decisions about your diet and medications.